Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Pindac)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004389 AN007332 Longitudinal Multi-omics Profiling Reveals Different Adaptation to Heat Stress in Genomically Divergent Lactating Sows Feces Pig Environmental stress North Carolina State University LC-MS
ST004389 AN007332 Longitudinal Multi-omics Profiling Reveals Different Adaptation to Heat Stress in Genomically Divergent Lactating Sows Milk Pig Environmental stress North Carolina State University LC-MS
ST004153 AN006894 Multi-omics Study of Small Intestine Adaptation After Total Colectomy in a Rat model Feces Rat Shanghai Jiao Tong University LC-MS
ST002711 AN004393 Metabolomic analysis of maternal mid-gestation plasma and cord blood: biogenic amines Blood Human Autism Columbia University LC-MS
ST002405 AN003919 Stool global metabolite levels in peanut allergy (Part 2) Feces Human Peanut allergy Icahn School of Medicine at Mount Sinai LC-MS
ST002094 AN003420 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic LC-MS
ST001324 AN002202 Metabolomics Adaptation of Juvenile Pacific Abalone Haliotis discus hannai to Heat Stress Hepatopancreas Pacific Abalone Institute of Oceanology, Chinese Academy of Sciences LC-MS
ST000422 AN000667 Type 1 Diabetes good glycemic control and controls samples Blood Human Diabetes Mayo Clinic LC-MS
ST000422 AN000669 Type 1 Diabetes good glycemic control and controls samples Blood Human Diabetes Mayo Clinic LC-MS
ST000421 AN000663 ms3076 T1D poor glycemic control and control samples Blood Human Diabetes Mayo Clinic LC-MS
ST000421 AN000665 ms3076 T1D poor glycemic control and control samples Blood Human Diabetes Mayo Clinic LC-MS
ST000047 AN000080 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) Cerebrospinal fluid Human Alzheimers disease Mayo Clinic LC-MS
ST000047 AN000081 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) Cerebrospinal fluid Human Alzheimers disease Mayo Clinic LC-MS
ST000046 AN000076 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic LC-MS
ST000046 AN000077 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic LC-MS
  logo